| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 337.01M | 310.71M | 306.37M | 167.72M | 145.14M |
| Gross Profit | 149.07M | 136.43M | 147.40M | 100.17M | 93.48M |
| EBITDA | 92.00M | 60.03M | 77.25M | 55.71M | 61.13M |
| Net Income | 39.33M | 19.19M | 35.69M | 34.71M | 39.68M |
Balance Sheet | |||||
| Total Assets | 503.81M | 508.35M | 519.11M | 479.99M | 232.13M |
| Cash, Cash Equivalents and Short-Term Investments | 150.17M | 33.19M | 86.77M | 160.45M | 24.30M |
| Total Debt | 142.21M | 105.49M | 98.77M | 100.42M | 51.79M |
| Total Liabilities | 427.98M | 411.03M | 397.95M | 368.27M | 148.88M |
| Stockholders Equity | 74.09M | 93.21M | 121.16M | 111.71M | 83.26M |
Cash Flow | |||||
| Free Cash Flow | 37.45M | 5.62M | 37.78M | 81.00M | 11.76M |
| Operating Cash Flow | 45.53M | 24.39M | 53.99M | 93.70M | 22.57M |
| Investing Cash Flow | -27.92M | -43.90M | -16.33M | -57.05M | -4.68M |
| Financing Cash Flow | -19.96M | -34.08M | -28.81M | 17.06M | -58.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | £840.97M | 16.56 | 64.69% | 5.54% | 1.58% | -6.06% | |
77 Outperform | £150.62M | 13.45 | 104.64% | 7.02% | 1.57% | 1.80% | |
68 Neutral | £429.64M | 45.76 | 6.99% | ― | 25.86% | 225.77% | |
64 Neutral | £351.27M | 9.02 | 17.25% | 20.30% | 8.46% | 120.34% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £731.37M | 78.76 | 4.01% | ― | 4.39% | -33.33% | |
48 Neutral | £48.16M | -8.28 | -32.65% | ― | -5.08% | -97.88% |